Potent in vivo lung cancer Wnt signaling inhibition via cyclodextrin-LGK974 inclusion complexes
Activation of the Wnt signaling pathway promotes lung cancer progression and contributes to poor patient prognosis. The porcupine inhibitor LGK974, a novel orally bioavailable cancer therapeutic in Phase I clinical trials, induces potent Wnt signaling inhibition and leads to suppressed growth and pr...
Main Authors: | Guimaraes, Pedro P G, Tan, Mingchee, Tammela, Tuomas, Wu, Katherine, Chung, Amanda T, Oberli, Matthias, Wang, Karin, Spektor, Roman, Riley, Rachel S., Viana, Celso T.R., Jacks, Tyler E, Langer, Robert S, Mitchell, Michael J. |
---|---|
Other Authors: | Massachusetts Institute of Technology. Department of Chemical Engineering |
Format: | Article |
Language: | English |
Published: |
Elsevier BV
2020
|
Online Access: | https://hdl.handle.net/1721.1/126038 |
Similar Items
-
Targeting of Deregulated Wnt/β-Catenin Signaling by PRI-724 and LGK974 Inhibitors in Germ Cell Tumor Cell Lines
by: Silvia Schmidtova, et al.
Published: (2021-04-01) -
A note on the bicategory of Landau-Ginzburg models (ℒ𝒢K)
by: Yves Baudelaire Fomatati
Published: (2024-02-01) -
Model‐based dose selection to inform translational clinical oncology development of WNT974, a first‐in‐class Porcupine inhibitor
by: Yan Ji, et al.
Published: (2022-07-01) -
9.74 Foundations of Human Memory and Learning, Spring 2002
by: Wagner, Anthony
Published: (2010) -
Combination of artesunate and WNT974 induces KRAS protein degradation by upregulating E3 ligase ANACP2 and β-TrCP in the ubiquitin–proteasome pathway
by: Rui-Hong Gong, et al.
Published: (2022-03-01)